Navigation Links
'Swine Flu' Shot May Be Cleared of Guillain-Barre Charges
Date:7/13/2011

WEDNESDAY, July 13 (HealthDay News) -- A new European study finds that the supercharged vaccines used to fight the H1N1 epidemic in 2009 may not have boosted the risk for a disease known as Guillain-Barre syndrome after all.

Guillain-Barre is a rare disorder, which causes a person's immune system to damage nerve cells, resulting in muscle weakness and even paralysis.

In 1976, a vaccine used during a U.S. flu outbreak was linked to the disease, and the government halted vaccination. Debate has continued since then over whether vaccines in use could trigger the syndrome.

In a study published July 13 in the journal BMJ, a consortium of researchers reported that the H1N1 vaccine posed little, if any, increased risk for the disease.

"This study provides reassurance that adjuvanted pandemic influenza A (H1N1) 2009 vaccines did not increase the risk of Guillain-Barre syndrome substantially, if at all," they wrote in a journal news release.

Their conclusion stemmed from an analysis of 50 million people in five European countries that vaccinated people against H1N1 in 2009. The researchers compared 104 people with Guillain-Barre syndrome or a related condition to other people without the diseases.

The researchers adjusted their statistics to account for other risk factors for the diseases and found no link between flu vaccination and Guillain-Barre syndrome. Still, noting that it's possible a small risk might remain, they estimated there may be less than three extra cases of Guillain-Barre syndrome for each one million people who get protected by a flu vaccination.

Larger studies already in progress should provide even more definitive information, the study authors added.

More information

For more about flu vaccination, visit the U.S. National Library of Medicine.

-- Randy Dotinga

SOURCE: BMJ, news release, July 12, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Swine flu spread was much wider than first thought, scientists say
2. Tracking Swine Flu Virus in Pigs Reveals Mutations
3. A Year After Its Emergence, H1N1 Swine Flu Lingers
4. Officials See Uptick in H1N1 Swine Flu Cases
5. Swine Flu vaccination: voluntary system works
6. 96 percent of vasectomy patients cleared without need for multiple semen samples
7. Guillain-Barre Syndrome Very Rare After H1N1 Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
'Swine Flu' Shot May Be Cleared of Guillain-Barre Charges
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, ... lowdown on sciatica in a new episode of "Success Files," which is an ... and innovation and investigates each subject in-depth with passion and integrity. , Sciatica ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), ... will showcase a range of technology and learning solutions at the 68th Annual ... Expo to be held October 14–18, 2017 at the Mandalay Bay Resort in ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one ... an innovative new design of the shoulder pad. The shoulder pad provides optimal ... controlling your pain while using cold therapy. By utilizing ice and water that is ...
(Date:10/12/2017)... LOS ANGELES (PRWEB) , ... October 12, 2017 ... ... of Parsa Mohebi Hair Restoration, has recently contributed a medical article to the ... doctors, on cosmetictown.com. Dr. Mohebi’s article spotlights the hair transplant procedure known as ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand ... Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness will be ... Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Sept. 28, 2017 Cohen Veterans Bioscience and ... use of wearable and home sensors for real-time monitoring ... Signal Foundation, a nonprofit organization focused on disruptive health ... an affordable analytical system to record and integrate behavioral, ... ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
(Date:9/19/2017)... a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed ...   ... Jim Bertolina, ... Tom Tefft ... medical device executive Josh Stopek , PhD, who has led R&D and business development ...
Breaking Medicine Technology: